## MHK: Mohawk Industries, Inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.93 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-4.8% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($101.54)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 8
- **Sentiment:** Bearish (Bullish: 0, Bearish: 0)

**1. Mohawk Industries-Bremworth deal faces regulatory pushback in New Zealand**
- Source: Law360 | 20251218T180832 | Somewhat-Bearish | Relevance: 100%
- Mohawk Industries' proposed acquisition of Bremworth, a carpet-manufacturing peer, is facing regulatory hurdles in New Zealand. The New Zealand Commerce Commission announced it will publish a statement of issues detailing potential competition concerns after its initial investigation. The regulator noted an overlap in the national manufacture and wholesale supply of carpets between Godfrey Hirst New Zealand (an interconnected body corporate of Mohawk) and Bremworth.

**2. Mohawk Industries Stock: Is MHK Underperforming the Consumer Discretionary Sector?**
- Source: inkl | 20251218T140832 | Somewhat-Bearish | Relevance: 100%
- Mohawk Industries (MHK) has underperformed the Consumer Discretionary sector and its peer Interface (TILE) over several periods, with its shares down significantly from its 52-week high. The company reported disappointing third-quarter results with modest sales growth but a decline in EPS, missing analyst expectations. Despite this, Wall Street analysts maintain a "Moderate Buy" rating with a substantial potential upside to the stock.

**3. Mohawk Industries (NYSE:MHK) Insider Suzanne Helen Sells 2,700 Shares**
- Source: MarketBeat | 20251217T230135 | Somewhat-Bearish | Relevance: 100%
- Mohawk Industries (NYSE:MHK) insider Suzanne Helen sold 2,700 shares of the company's stock on December 17th, totaling $294,300. This transaction reduced her position by 3.82%, leaving her with 67,893 shares. The company's stock is currently trading around $109, with analysts holding a "Moderate Buy" consensus and a mean target price of $135.79.

**4. Mohawk Industries (NYSE:MHK) Insider Sells $221,400.00 in Stock**
- Source: MarketBeat | 20251217T230035 | Somewhat-Bearish | Relevance: 100%
- Mohawk Industries (NYSE:MHK) Director Suzanne Helen sold 2,000 shares of company stock for $221,400 on December 15th, reducing her stake by 2.63%. This transaction occurred as the company's shares traded down, and follows a recent earnings report where Mohawk missed EPS estimates but beat revenue expectations. Analysts have a "Moderate Buy" consensus rating with a price target of $135.79 for the company.

**5. Insider Selling: Mohawk Industries (NYSE:MHK) Insider Sells 3,500 Shares of Stock**
- Source: MarketBeat | 20251217T230035 | Somewhat-Bearish | Relevance: 100%
- Mohawk Industries (NYSE:MHK) insider Suzanne Helen sold 3,500 shares at an average price of $110.36, totaling $386,260, reducing her stake by 4.72%. The company's stock traded down 0.9% to $109.26, with a market cap near $6.75 billion and a P/E of 16.26. Analysts currently rate MHK as "Moderate Buy" with a consensus target price of $135.79.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 4)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Jefferies | $128 | $134 | -4% |
| 2025-12-15 | Wells Fargo | $110 | $125 | -12% |
| 2025-12-04 | Wells Fargo | $125 | $130 | -4% |
| 2025-11-19 | Evercore ISI Gr | $118 | $124 | -5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Jefferies | main | Hold |
| 2025-12-15 | Wells Fargo | main | Equal-Weight |
| 2025-12-04 | Wells Fargo | main | Equal-Weight |
| 2025-11-19 | Evercore ISI Gr | main | In-Line |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 15 ($1.91M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (-1.2%)
- JPMORGAN CHASE & CO: 8.2% (+44.8%)
- Blackrock Inc.: 5.5% (-0.7%)
- Dimensional Fund Adv: 5.0% (+1.2%)
- FMR, LLC: 3.4% (+56.4%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-4.8% 5d) with bearish MACD, trend may be turning.
2. Long-term trend broken: trading 5.9% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.93 indicates undervaluation relative to growth. Forward P/E 10.8x attractive for 11% earnings growth. Balance sheet: strong liquidity (2.2x). Analyst sentiment negative (4 target cuts vs 0 raises). Insider selling cluster ($1.9M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $6.7B |
| Beta | 1.24 |
| 52W Range | $96.24 - $143.13 |
| Short Interest | 5.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.93 |
| Forward P/E | 10.8 |
| Current P/E | 12.1 |
| YoY Growth | 11.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 1.0% to -3.8% (-4.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.8pp (needs >4.0% for momentum thesis). AM_20 at -3.5% indicates price below own 20MA trend. Underperforming sector by 5.9pp, stock-specific weakness. Below SMA200 (0.94x), long-term trend not supportive. RSI neutral at 41. Elevated volume (5.0x 20MA), institutional activity likely. OFD pattern: -SLH (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.78% (CS: 16) | Weak |
| RSI_14 | 40.9 | Neutral |
| MACD Histogram | -0.07 | Bearish |
| vs SMA20 | 0.965x | Below |
| vs SMA50 | 0.945x | Below |
| vs SMA200 | 0.941x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $107.80
- **Stop Loss:** $101.54 (5.8% risk)
- **Target:** $120.32 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 143
- **Position Value:** $15,415.40
- **Portfolio %:** 15.42%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-12 (Est: $1.98)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.64 | $2.67 | +1.2% |
| 2025Q2 | $2.61 | $2.77 | +6.3% |
| 2025Q1 | $1.41 | $1.52 | +8.2% |
| 2024Q4 | $1.85 | $1.95 | +5.3% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*